Literature DB >> 17014835

Effects of a pomegranate fruit extract rich in punicalagin on oxidation-sensitive genes and eNOS activity at sites of perturbed shear stress and atherogenesis.

Filomena de Nigris1, Sharon Williams-Ignarro, Vincenzo Sica, Lilach O Lerman, Francesco P D'Armiento, Russell E Byrns, Amelia Casamassimi, Daniela Carpentiero, Concetta Schiano, Daigo Sumi, Carmela Fiorito, Louis J Ignarro, Claudio Napoli.   

Abstract

BACKGROUND: Atherosclerosis is enhanced in arterial segments exposed to disturbed flow. Perturbed shear stress increases the expression of oxidation-sensitive responsive genes (such as ELK-1 and p-CREB). Polyphenolic antioxidants contained in the juice derived from the pomegranate contribute to the reduction of oxidative stress and atherogenesis during disturbed shear stress. AIM OF THE STUDY: To evaluate the effects of intervention with the Pomegranate Fruit Extract (PFE) rich in polyphones (punicalagin, which is a potent antioxidant) on ELK-1, p-CREB, and endothelial nitric oxide synthase (eNOS) expression induced by high shear stress in vitro and in vivo.
RESULTS: At the doses used in the study, both the PFE and the regular pomegranate juice concentrate reduced the activation of ELK-1 and p-CREB and increased eNOS expression (which was decreased by perturbed shear stress) in cultured human endothelial cells and in atherosclerosis-prone areas of hypercholesterolemic mice. PFE and pomegranate juice increased cyclic GMP levels while there was no significant effect of both compounds on the conversion of L-arginine to L-citrulline. Administration of these compounds to hypercholesterolemic mice significantly reduced the progression of atherosclerosis and isoprostane levels and increased nitrates. This protective effect was relevant with PFE. Vasomotor reactivity was improved and EC(25) values in response to Ach and NONOate were significantly increased in treated mice in comparison to controls.
CONCLUSION: This study indicates that the proatherogenic effects induced by perturbed shear stress can be also reversed by chronic administration of PFE.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17014835     DOI: 10.1016/j.cardiores.2006.08.021

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  20 in total

1.  Pomegranate juice and punicalagin attenuate oxidative stress and apoptosis in human placenta and in human placental trophoblasts.

Authors:  Baosheng Chen; Methodius G Tuuli; Mark S Longtine; Joong Sik Shin; Russell Lawrence; Terrie Inder; D Michael Nelson
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-02-28       Impact factor: 4.310

2.  Reduction of cisplatin ototoxicity in rats by oral administration of pomegranate extract.

Authors:  Zahide Mine Yazici; Aysenur Meric; Ahmet Midi; Yasar Volkan Arınc; Volkan Kahya; Gunter Hafız
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-03-27       Impact factor: 2.503

3.  Cardioprotective and hepatoprotective effects of ellagitannins from European oak bark (Quercus petraea L.) extract in rats.

Authors:  Sunil K Panchal; Lindsay Brown
Journal:  Eur J Nutr       Date:  2011-11-22       Impact factor: 5.614

4.  Pomegranate extract alleviates disease activity and some blood biomarkers of inflammation and oxidative stress in Rheumatoid Arthritis patients.

Authors:  M Ghavipour; G Sotoudeh; E Tavakoli; K Mowla; J Hasanzadeh; Z Mazloom
Journal:  Eur J Clin Nutr       Date:  2016-08-31       Impact factor: 4.016

5.  Consumption of hydrolyzable tannins-rich pomegranate extract suppresses inflammation and joint damage in rheumatoid arthritis.

Authors:  Meenakshi Shukla; Kalpana Gupta; Zafar Rasheed; Khursheed A Khan; Tariq M Haqqi
Journal:  Nutrition       Date:  2008-05-19       Impact factor: 4.008

6.  Punicalagin exerts protective effect against high glucose-induced cellular stress and neural tube defects.

Authors:  Jianxiang Zhong; E Albert Reece; Peixin Yang
Journal:  Biochem Biophys Res Commun       Date:  2015-10-13       Impact factor: 3.575

7.  Pharmacological investigations of Punica granatum in glycerol-induced acute renal failure in rats.

Authors:  Amrit Pal Singh; Amteshwar Jaggi Singh; Nirmal Singh
Journal:  Indian J Pharmacol       Date:  2011-09       Impact factor: 1.200

8.  Punicalagin Attenuates Disturbed Flow-Induced Vascular Dysfunction by Inhibiting Force-Specific Activation of Smad1/5.

Authors:  Gulinigaer Anwaier; Guan Lian; Gui-Zhi Ma; Wan-Li Shen; Chih-I Lee; Pei-Ling Lee; Zhan-Ying Chang; Yun-Xia Wang; Xiao-Yu Tian; Xiao-Li Gao; Jeng-Jiann Chiu; Rong Qi
Journal:  Front Cell Dev Biol       Date:  2021-06-28

9.  The natural antioxidants, pomegranate extract and soy isoflavones, favourably modulate canine endothelial cell function.

Authors:  Sabina M Baumgartner-Parzer; Ferdinand Rudolf Waldenberger; Angelika Freudenthaler; Amandine Ginouvès-Guerdoux; David McGahie; Hugues Gatto
Journal:  ISRN Vet Sci       Date:  2012-11-26

10.  Bioavailable constituents/metabolites of pomegranate (Punica granatum L) preferentially inhibit COX2 activity ex vivo and IL-1beta-induced PGE2 production in human chondrocytes in vitro.

Authors:  Meenakshi Shukla; Kalpana Gupta; Zafar Rasheed; Khursheed A Khan; Tariq M Haqqi
Journal:  J Inflamm (Lond)       Date:  2008-06-13       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.